The CHR-P assessment should be offered to help-seeking individuals or those with well-established neurodevelopmental conditions (e.g., autism, ADHD, dyspraxia, learning disabilities) that confer an increased risk of psychosis. In this context, disseminating knowledge on psychosis clinical staging and CHR-P assessment, alongside strengthening collaboration between pediatricians and child and adolescent mental health services (CAMHS), represents a crucial strategic priority.
Clinical High Risk for Psychosis (CHR-P) in children and adolescents: a roadmap to strengthen clinical utility through conceptual clarity
Preti, AntonioLast
2024-01-01
Abstract
The CHR-P assessment should be offered to help-seeking individuals or those with well-established neurodevelopmental conditions (e.g., autism, ADHD, dyspraxia, learning disabilities) that confer an increased risk of psychosis. In this context, disseminating knowledge on psychosis clinical staging and CHR-P assessment, alongside strengthening collaboration between pediatricians and child and adolescent mental health services (CAMHS), represents a crucial strategic priority.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Clinical High Risk for Psychosis (CHR‑P) in children and adolescents.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
498.01 kB
Formato
Adobe PDF
|
498.01 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
